Eurofins Scient (OTCMKTS:ERFSF) Sees Large Volume Increase – Here’s What Happened

Shares of Eurofins Scient (OTCMKTS:ERFSFGet Free Report) saw unusually-high trading volume on Monday . Approximately 13,627 shares were traded during mid-day trading, an increase of 146% from the previous session’s volume of 5,534 shares.The stock last traded at $69.6275 and had previously closed at $70.95.

Analyst Ratings Changes

Several brokerages have commented on ERFSF. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research note on Monday, February 2nd. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

View Our Latest Research Report on Eurofins Scient

Eurofins Scient Stock Down 2.3%

The company has a 50 day moving average of $75.46 and a two-hundred day moving average of $74.89.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Featured Articles

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.